Two Sigma Advisers’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,900
Closed -$944K 568
2025
Q4
$944K Sell
13,900
-18,500
-57% -$1.16M ﹤0.01% 1504
2025
Q3
$1.85M Buy
32,400
+22,800
+238% +$1.35M ﹤0.01% 1167
2025
Q2
$532K Buy
+9,600
New +$450K ﹤0.01% 1721
2025
Q1
Sell
-8,200
Closed -$353K 2430
2024
Q4
$353K Sell
8,200
-4,400
-35% -$198K ﹤0.01% 1911
2024
Q3
$563K Sell
12,600
-15,500
-55% -$641K ﹤0.01% 1648
2024
Q2
$1.08M Buy
28,100
+22,000
+361% +$838K ﹤0.01% 1514
2024
Q1
$210K Buy
+6,100
New +$196K ﹤0.01% 2199

Other funds holding DBD

Two Sigma Advisers's DBD Position: Q1 2026 in Review

Two Sigma Advisers sold out of Diebold Nixdorf (DBD) in Q1 2026, closing a stake of 13,900 shares — an estimated $944K sold.

Two Sigma Advisers first reported a position in DBD in Q1 2024 and held it in 7 quarters. The position peaked at $1.85M in Q3 2025. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Two Sigma Advisers reported no remaining Diebold Nixdorf position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 13,900 Diebold Nixdorf shares in Q1 2026, an estimated $944K.
  • Two Sigma Advisers first reported a position in Diebold Nixdorf in Q1 2024 and held it in 7 quarters.
  • Two Sigma Advisers's Diebold Nixdorf position peaked at $1.85M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.